At the heart of the Oncopole
At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT leads an integrated approach between research, care and teaching, in a transversal and multidisciplinary logic.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Researchers, clinicians and supports
PhD students and post-doctoral fellows
IMLINFO is a cross-border network of personalized immunotherapies for Non-Hodgkin's lymphomas (NHL) involving 7 organizations located in Spain and France. Its main objective is to determine the efficacy of new immunotherapy treatments through the creation of a NHL...read more
Publication team 2 (J.S. Hoffmann) / ARTEMIS and XPF-ERCC1: 2 nucleases to prevent genetic instability
Bétous, R., Goullet de Rugy, T., Pelegrini, A.L., Queille, S., de Villartay, J.-P., & Hoffmann, J.-S.*, 2018. DNA replication stress triggers Rapid DNA Replication Fork Breakage by Artemis and XPF. PLoS Genet. 14, e1007541. DNA replication stress (DRS) leads to...read more
Discover in this France 3 TV report the collaboration between the CRCT team led by Dr. Pierre Cordelier and the Toulouse start-up Neovirtech: a therapeutic innovation opening up new perspectives in the treatment of cancer. [video width="960" height="540"...read more
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE